Your browser doesn't support javascript.
loading
Total cardiovascular or fatal events in people with type 2 diabetes and cardiovascular risk factors treated with dulaglutide in the REWIND trail: a post hoc analysis.
Dagenais, Gilles R; Rydén, Lars; Leiter, Lawrence A; Lakshmanan, Mark; Dyal, Leanne; Probstfield, Jeffrey L; Atisso, Charles Messan; Shaw, Jonathan E; Conget, Ignacio; Cushman, William C; Lopez-Jaramillo, Patricio; Lanas, Fernando; Munoz, Ernesto German Cordona; Pirags, Valdis; Pogosova, Nana; Basile, Jan; Sheu, Wayne H H; Temelkova-Kurktschiev, Theodora; Raubenheimer, Peter J; Keltai, Matyas; Hall, Stephanie; Pais, Prem; Colhoun, Helen M; Riddle, Matthew C; Gerstein, Hertzel C.
  • Dagenais GR; Clinical Research Center, Laval University, Quebec Heart and Lung Institute, 2725, chemin Ste-Foy, Quebec City, Qc, GIV 4G5, Canada. gilles.dagenais@criucpq.ulaval.ca.
  • Rydén L; Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.
  • Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada.
  • Lakshmanan M; Eli Lilly and Company, Indianapolis, In, USA.
  • Dyal L; Population Health Research Institute, McMaster University and Hamilton Health Science, Hamilton, ON, Canada.
  • Probstfield JL; Department of Medicine (Cardiology), University of Washington Medical Centre, Seattle, WA, USA.
  • Atisso CM; Eli Lilly and Company, Indianapolis, In, USA.
  • Shaw JE; Baker Heart and Diabetes Institute, Melbourne, VIC, Australia.
  • Conget I; Endocrinology and Nutrition Department, Hospital Clinic i Universitari, Barcelona, Spain.
  • Cushman WC; Department of Medicine, University of Tennessee Health Science, Memphis, TN, USA.
  • Lopez-Jaramillo P; Masira Research Institute, Medical School, Universidad de Santander UDES, Bucaramanga, Colombia.
  • Lanas F; Universidad de la Frontera, Temuco, Chile.
  • Munoz EGC; Universidad de Guadalajara Centro Universitario de Ciencias de la Salud, Guadalajara, Mexico.
  • Pirags V; Latvijas Universitate, Riga, Latvia.
  • Pogosova N; National Medical Research Centre of Cardiology, Moscow, Russia.
  • Basile J; Medical University of South Carolina, Charleston and Ralph H Johnson VA Medical Center, Charleston, SC, USA.
  • Sheu WHH; Endocrinology and Metabolism, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Temelkova-Kurktschiev T; Robert Koch Medical Centre, Sofia, Bulgaria.
  • Raubenheimer PJ; Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Keltai M; Semmelweis University, Hungarian Institute of Cardiology, Budapest, Hungary.
  • Hall S; Population Health Research Institute, McMaster University and Hamilton Health Science, Hamilton, ON, Canada.
  • Pais P; St John's Research Institute, Bangalore, India.
  • Colhoun HM; MRC Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
  • Riddle MC; Department of Medicine, Oregon and Health Science University, Portland, OR, USA.
  • Gerstein HC; Population Health Research Institute, McMaster University and Hamilton Health Science, Hamilton, ON, Canada.
Cardiovasc Diabetol ; 19(1): 199, 2020 11 25.
Article en En | MEDLINE | ID: mdl-33239067
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Fragmentos Fc de Inmunoglobulinas / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Péptidos Similares al Glucagón / Incretinas / Hipoglucemiantes Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Recombinantes de Fusión / Fragmentos Fc de Inmunoglobulinas / Enfermedades Cardiovasculares / Diabetes Mellitus Tipo 2 / Péptidos Similares al Glucagón / Incretinas / Hipoglucemiantes Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2020 Tipo del documento: Article